Hallmark Capital Management Inc Edwards Lifesciences Corp Transaction History

Hallmark Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$74.26 - $84.51 $164,560 - $187,274	-2,216 Reduced 73.47%	800 $66,000
Q4 2022 Feb 01, 2023	SELL	$68.3 - $87.44 $5,395 - $6,907	-79 Reduced 2.55%	3,016 $225,000
Q3 2022 Nov 09, 2022	BUY	$82.37 - $107.29 $32,618 - $42,486	396 Added 14.67%	3,095 $256,000
Q2 2022 Nov 16, 2022	SELL	$86.5 - $128.27 $34,254 - $50,794	-396 Reduced 12.79%	2,699 $257,000
Q2 2022 Aug 01, 2022	SELL	$86.5 - $128.27 $162,879 - $241,532	-1,883 Reduced 41.1%	2,699 $257,000
Q1 2022 May 02, 2022	BUY	$101.96 - $128.34 $24,776 - $31,186	243 Added 5.6%	4,582 $540,000
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $34,463 - $42,340	324 Added 8.07%	4,339 $563,000
Q3 2021 Nov 01, 2021	BUY	$102.91 - $122.75 $166,199 - $198,241	1,615 Added 67.29%	4,015 $454,000
Q4 2020 Feb 02, 2021	BUY	$71.69 - $91.23 $172,056 - $218,952	2,400 New	2,400 $219,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Hallmark Capital Management Inc with notifications on news.